Improvements in SLE Disease Activity Across Multiple Organ Systems with Intravenous and Subcutaneous Anifrolumab Treatment: Pooled Analysis of 3 Phase 3 Trials (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2212; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
P3 data • Retrospective data • Inflammatory Arthritis
|